Cargando…
1402. Expand accessibility of monoclonal antibody in COVID-19 among different ethnicities and races.
BACKGROUND: Anti-SARS-CoV-2 monoclonal antibodies are administered to patients with mild-moderate COVID-19 who are at high risk of progression to severe disease. It has been shown that in addition to medical comorbidities, race or ethnicity may also place patients at high risk for progression to sev...
Autores principales: | Farooq, Hina, Shankaran, Shivanjali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752574/ http://dx.doi.org/10.1093/ofid/ofac492.1231 |
Ejemplares similares
-
1402. The Landscape of Infections Caused by Rare Bacterial Pathogens
por: Farid, Tahsin, et al.
Publicado: (2023) -
Race and Ethnic Group Differences in Social Engagement Among Older Adults
por: Quach, Lien, et al.
Publicado: (2021) -
Differences in Self-Rated Memory by Race/Ethnicity
por: Franco, Yujin, et al.
Publicado: (2021) -
Nezahualcóyotl, Acolmiztli, 1402-1472
por: Alva Ixtlilxóchitl, Fernando de, 1402-1472
Publicado: (1972) -
2007. To Treat or Not to Treat: Does a More Sensitive and Specific Testing Methodology Make the Treatment Decision More Clear?
por: Kulla, Bakri, et al.
Publicado: (2018)